US EditionMRI-Based Fusion Model Determines HER2 Status in Breast Cancer
Summary by auntminnie.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Chicago – With the support of artificial intelligence (AI), pathologists are better able to detect breast cancers with low (HER2-low) and very low (HER2-ultralow) expression of the human epidermal growth factor receptor 2 (HER2). Misclassification as HER2-null was observed significantly less frequently, according to the results...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
